Clinical Trial Results: Osteoporosis

Product Name: Bonviva/Boniva [ibandronate]
Date of Report: 8/1/2000
Phase: II
Open-label, single-arm, multicenter study on the efficacy and safety of intermittent, intravenous administration if BM 21.0955 (2.0 mg every 3 months) during 12 months’ treatment of corticosteroid-induced osteoporosis.

Product Name: Bonviva/Boniva [ibandronate]
Date of Report: 9/1/2001
Phase: II
Open, monocenter, pilot-study on the efficacy and safety of intermittent, intravenous administration of BM 21.0955 (2.0 mg every three months) during 2 years’ treatment in male patients with osteoporosis.

Product Name: Bonviva/Boniva [ibandronate]
Date of Report: To be Published
Phase: III
BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.